BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 60 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9 | -93.5% | 41,700 | -37.9% | 0.00% | – |
Q2 2023 | $139 | -61.1% | 67,200 | -37.8% | 0.00% | – |
Q1 2023 | $357 | +101.7% | 108,000 | 0.0% | 0.00% | – |
Q4 2022 | $177 | -100.0% | 108,000 | 0.0% | 0.00% | – |
Q3 2022 | $478,000 | +86.0% | 108,000 | +16.1% | 0.00% | – |
Q2 2022 | $257,000 | -17.6% | 93,000 | 0.0% | 0.00% | – |
Q1 2022 | $312,000 | -16.1% | 93,000 | 0.0% | 0.00% | – |
Q4 2021 | $372,000 | +21.2% | 93,000 | 0.0% | 0.00% | – |
Q3 2021 | $307,000 | -13.0% | 93,000 | 0.0% | 0.00% | – |
Q2 2021 | $353,000 | -24.6% | 93,000 | -23.9% | 0.00% | – |
Q1 2021 | $468,000 | +372.7% | 122,161 | +460.2% | 0.00% | – |
Q4 2020 | $99,000 | -44.4% | 21,806 | +107.3% | 0.00% | – |
Q3 2020 | $178,000 | – | 10,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,500 | $825,000 | 0.55% |
SABBY MANAGEMENT, LLC | 136,484 | $27,310 | 0.02% |
LIBERTY WEALTH MANAGEMENT LLC | 352,619 | $71 | 0.02% |
Weaver Consulting Group | 99,356 | $19,881 | 0.01% |
ABNER HERRMAN & BROCK LLC | 145,500 | $29 | 0.00% |
JMAC ENTERPRISES LLC | 65,430 | $13,093 | 0.00% |
Professional Financial Advisors, LLC | 17,279 | $3,458 | 0.00% |
Ikarian Capital, LLC | 90,242 | $18,057 | 0.00% |
MOORE CAPITAL MANAGEMENT, LP | 200,000 | $40,020 | 0.00% |
Weaver Consulting Group | 45,000 | $2,750 | 0.00% |